Arcutis Biotherapeutics Inc

NASDAQ:ARQT   11:35:36 AM EDT
19.37
+1.07 (+5.85%)
Mergers / Acquisitions

Lifearc Says Portfolio Co Ducentis Biotherapeutics Acquired By Arcutis Biotherapeutics For Up To $400 Mln

Published: 09/08/2022 06:11 GMT
Arcutis Biotherapeutics Inc (ARQT) - Lifearc Portfolio Company Ducentis Biotherapeutics Acquired by Arcutis Biotherapeutics for Up to $400 Million.
Lifearc - Agreement Values Ducentis at Up to $400 Million, Including Upfront Cash Payment of $16 Million and Arcutis Stock Valued at Approximately $14 Million.